|
SKAP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.853000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.396100E-02 |
| Normal-vs-Stage2 |
3.470800E-01 |
| Normal-vs-Stage3 |
4.509800E-01 |
| Normal-vs-Stage4 |
2.213200E-01 |
| Stage1-vs-Stage2 |
7.949200E-01 |
| Stage1-vs-Stage3 |
7.622200E-02 |
| Stage1-vs-Stage4 |
1.287720E-02 |
| Stage2-vs-Stage3 |
1.906590E-01 |
| Stage2-vs-Stage4 |
1.241580E-01 |
| Stage3-vs-Stage4 |
7.884600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.138000E-01 |
| Normal-vs-AfricanAmerican |
1.388400E-01 |
| Normal-vs-Asian |
3.641200E-01 |
| Caucasian-vs-AfricanAmerican |
4.563900E-02 |
| Caucasian-vs-Asian |
3.845200E-01 |
| AfricanAmerican-vs-Asian |
8.798000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.295000E-01 |
| Normal-vs-Female |
2.742200E-01 |
| Male-vs-Female |
3.283000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.426000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.310600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.852400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.336000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.994000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.559800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.558400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.125600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.041000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.717200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.709790E-01 |
| Normal-vs-Grade 2 |
1.063150E-01 |
| Normal-vs-Grade 3 |
9.506400E-01 |
| Normal-vs-Grade 4 |
2.224400E-02 |
| Grade 1-vs-Grade 2 |
4.542200E-01 |
| Grade 1-vs-Grade 3 |
9.913600E-02 |
| Grade 1-vs-Grade 4 |
1.321720E-02 |
| Grade 2-vs-Grade 3 |
1.242770E-01 |
| Grade 2-vs-Grade 4 |
1.121050E-03 |
| Grade 3-vs-Grade 4 |
1.784360E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.100930E-03 |
| Normal-vs-ccB subtype |
3.958800E-01 |
| ccA subtype-vs-ccB subtype |
6.411700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.504240E-01 |
| Normal-vs-N1 |
7.222400E-01 |
| N0-vs-N1 |
4.160200E-01 |
|
|
